Although results obtained in baboons and rats have demonstrated that the fatty acid cyclo-oxygenase inhibitor indomethacin reduces cerebral blood flow (CBF) under control conditions and markedly attenuates the CBF response to hypercapnia, nonconfirmatory results have been obtained in rab bits and cats. Since these latter studies were carried out under barbiturate anesthesia, we tested the effect of indomethacin (10 mg kg-I) on CBF and cerebral oxygen consumption in rats anesthetized with 150 mg kg-1 of phenobarbital. At normocapnia the barbiturate reduced CBF, measured with a 133Xe modification of the Kety-Schmidt technique, to about 50% of nitrous oxide control values as previously determined with a similar technique. At this CBF level, indomethacin induced a small, albeit highly significant decrease in CBF, We suggest that a reduction of this magnitude will escape detection with some CBF techniques in current use. Indomethacin induced a highly significant decrease in CBF during hypercapnia, demonstrating that the barbiturate does not eliminate the effect of indomethacin on CO2 responsiveness. The magnitude of the reduction in CO2 response was so large that it should be detected with most methods for measuring CBF. A comparison with previous data on animals under 70% N20 demonstrated that phenobarbital reduced the CO2 respon siveness, defined as the ratio llCBFI llPC02, to 39% of that observed under nitrous oxide analgesia. With both types of anesthesia, indomethacin curtailed the CO2 responsiveness 4-to 5-fold. Key Words: Cerebral blood flow Cerebral metabolic rate-Normocapnia-Hypercapnia-Indomethacin.
In spite of the fact that the problem has been studied over many decades, the factors that adjust the cerebral blood flow (CBF) to functional and metabolic demands have not yet been defined. Re cent results indicate that some of these missing coupling factors may be provided by products of the fatty acid cyclo-oxygenase, i. e. , by prostaglandins and related substances. The evidence comes from 109 studies in which the cyclo-oxygenase was inhibited by indomethacin, a potent inhibitor of the enzyme in brain and other tissues (see Flower, 1974; Wolfe et aI. , 1976; Abdel-Halim et aI. , 1978) .
The original report describing an effect of in domethacin on CBF was published by Pickard and MacKenzie (1973) , who administered the drug by intravenous (10 mg kg-I) or intracarotid (0.04-0.2 mg kg-I min-I) routes in phencyclidine-N20 anesthetized baboons, measuring CBF with a 133Xe clearance technique. The authors found that the drug reduced control CBF by an average of 38% and that it markedly attenuated the CBF response to induced hypercapnia, without affecting the cerebral metabolic rate for oxygen (CMROz) . Subsequent studies from the same group demonstrated that in domethacin failed to affect the autoregulatory abil ity of the cerebral vasculature in response to changes in perfusion pressure (Pickard et aI. , 1977a) . Since experiments with intracarotid infu sion of prostaglandin E2 and F2a, with or without prior osmotic disruption of the blood-brain barrier, showed that these prostaglandins reduced both CBF and CMR02 (Pickard et ai. 1977b) , it seemed that indomethacin must have inhibited the forma tion of another cyclo-oxygenase product. Recent results (Pickard et aI. , 1980) indicate that this prod uct is prostacyclin, a "prostaglandin" which has been shown to be localized to vascular tissue and to mediate vasodilatation in other tissues than the brain (Moncada and Vane, 1978; Jarman et aI. , 1979; Chapleau et aI. , 1980) . Studies from our own laboratory have confirmed and extended the original observations of Pickard and MacKenzie (1973) . Thus, Sakabe and Siesjo (1979) , working on rats under NzO analgesia and measuring CBF with a 133Xe modification of the Kety and Schmidt technique, found that in domethacin (10 mg kg�l, Lv. ) decreased CBF to 50% of control and reduced CBF under hypercapnic conditions (PaC02 about 80 mm Hg) to about 30% of hypercapnic control, CMROz being unchanged both at normo-and hypercapnia. Since indomethacin did not curtail the circulatory response to hypoxia, a general unreactivity of the cerebral vasculature could be excluded. The reduction in CBF induced by indomethacin was verified with two completely different CBF techniques (Dahlgren et aI. , 198 1) based on autoradiographic assessment of local CBF with [14C]iodoantipyrine as the diffusible tracer and continuous cerebral venous outflow measurements, respectively. In that study, local CBF at normocap nia was reduced to 40-80% of control, with cere bral cortical structures having flow rates of 40-50% of control. A comparison showed that the relative (Le. , percentage) reduction in CBF, brought about by indomethacin, was similar in normocapnia and hypercapnia (see below). Two further results should be noted. First, effects on CBF were observed at an indomethacin dose of 1 mg kg� 1, and maximal ef fects were observed with 3-5 mg kg�l. Second, following intravenous administration of indometha cin, CBF began decreasing within 10 sec, and maximal effects were noted after about 2 min. These results indicate that the effect of indometha-J Cereb Blood Flow Metabol. Vol. I. No. 1, 1981 cin was related to cyclo-oxygenase inhibition (see Flower, 1974) and that the drug acted on an enzyme complex in fast diffusion equilibrium with blood (the vascular wall?).
Although the results obtained in baboons and rats appear convincing, nonconfirmatory results have nevertheless appeared. Cuypers et ai. (1978) , measuring relative changes in CBF with a thermo clearance technique in rabbits, reported that in domethacin neither reduced "resting" CBF nor attenuated the response to hypercapnia. Similar re sults were reported by Wei et al. (1980) , who mea sured pial artery caliber in cats. The experiments can be criticized on grounds that none of these techniques gives quantitative measures of blood flow (see Discussion). However, an even more important factor may be the barbiturate anesthesia used, since barbiturates by themselves reduce CBF and at tenuate the circulatory response to hypercapnia (Fujishima et aI. , 1971; Grubb et al. 1974) .
The present experiments were undertaken to as sess the effect of indomethacin on CBF and CMR02 under normocapnic and hypercapnic conditions in barbiturate-anesthetized animals. To that end, ven tilated rats maintained on phenobarbital anesthesia were exposed to hypercapnia, with or without prior administration of indomethacin in a dose of 10 mg kg�l.
MATERIALS AND METHODS

Materials
Phenobarbital (Fenemal®, 200 mg ml�l, ACO, Stockholm) and d-tubocurarine (Tubocurarine®, 3 mg ml�l, Vitrum, Stockholm) were used in stock solutions as supplied. Heparin (Vitrum, Stockholm) was diluted in Krebs solution to give a concentra tion of 300 IV ml�l. Indomethacin (Confortid®, Dumex, Helsingborg) was dissolved in distilled water to give a concentration of 10 mg ml�l. Thus, it was not necessary to use bicarbonate-containing solutions. pH in the solution was about 7. 70. Only freshly prepared solutions were used. Xenon-133 gas was provided by AB Atomenergi, Studsvik.
Animals
All experiments were performed on male Wistar rats (SPF strain, M�llegaards A vlslaboratorium, Copenhagen) weighing 305 -460 g. The animals had free access to tap water and food pellets (Astra Ewos, SOdertalje) until operation.
Operative and Sampling techniques
The rats were anesthetized by intraperitoneal in jection of phenobarbital 150 mg kg-I. When unre sponsive, the animals were tracheotomized and ar tificially ventilated with N �/02 (70: 30) by a Starling-type respirator. Immobilization was ac complished by d-tubocurarine, 1. 5 mg kg-I, i. v. Body temperature was controlled and kept close to 37°C by means of a heating bulb. Blood gas and pH measurements (Eschweiler and Co. , Kiel, and Radiometer, Copenhagen) were corrected for any deviation from this temperature. One brachial ar tery and a femoral artery and vein were cannulated to accomplish arterial sampling for 133Xe determi nation during desaturation, continuous blood pres sure recording, anaerobic sampling for blood gas analyses, injection of drugs, and transfusion of donor blood (see below). The skull was exposed by a small incision and a hole in the skull bone drilled 7-8 mm caudal to the bregma, giving access to cerebrovenous blood from the superior sagittal sinus. Heparin, 300 IU kg-I, was given intrave nously at the end of the operation. The animals were then allowed a steady-state period of 30 min before experimental procedures were instituted (see below). During that period, the Paco� was con trolled to the range of 35-40 mm Hg and Pao� in excess of 90 mm Hg.
Measurement of CBF and CMR02
CBF was measured using a modification of the Kety-Schmidt technique with 133Xe gas as the dif fusible tracer (Norberg and Siesjo, 1974; Berntman et aI. , 1979) . The animals were saturated for 20 min with 133Xe tracer gas added to the insufflated gas mixture. Desaturation curves were obtained by re peated sampling of arterial and cerebrovenous blood and the area between the curves was calcu lated by means of the trapezoid rule. A 133Xe parti tion coefficient of 0. 83 was used for calculating CBF. Total oxygen content was measured accord ing to Borgstrom et ai. (1974) in 4 pairs of ar teriocerebrovenous samples, 2 taken just prior to and 2 during the first minutes of desaturation. This gave a value for the arteriovenous oxygen differ ence (A VD02) that, multiplied by the CBF, gave CMR02• The experiment was discarded if values for A VD02 prior to and during flow measurement dif fered by more than 15%.
In order to avoid a fall in blood pressure during sampling of arterial and venous blood, fresh donor blood was infused intermittently (3 -5 mI).
Design of Experiments
Four conditions were studied: normocapnia and hypercapnia with and without indomethacin. In each of these four groups of animals, indomethacin or an equivalent amount of saline was injected at the end of the steady-state period and CBF measured 45 min later. In the two hypercapnic groups, 5 -6% CO2 was added to the insufflated gas mixture 15 min after indomethacin injection, i. e. , 30 min prior to CBF measurements. Since only one CBF-CMR02 determination was made for each animal, the length of anesthesia and the duration of indomethacin ac tion were similar in all animals.
Calculations
In calculating statistical differences, the homoge neity of variance was first tested. Depending on the outcome of this test, statistical calculations were performed by the Student's t-test or the Mann Whitney U-test.
RESULTS
Physiological Parameters
Mean values for body temperature and mean arterial blood pressure as well for arterial Po2, Pco2, and pH are given in Table 1 . Body temperature and arterial P02 were similar in all four groups. Both normocapnic groups had similar arterial Pco2 and pH values, and hypercapnia induced similar changes in these variables. It can thus be excluded that the results for CBF (or CMR02) were influ enced by differences in the physiological state of the animals.
CBF and CMR02
Previous results from the laboratory suggest that the Kety and Schmidt technique, modified for the rat, yields accurate values for CBF and CMR02 at normal and increased flow rates (see Siesjo et aI. , 1980) . In the present study, markedly reduced CBF values were encountered, as compared with nitrous oxide anesthesia. Figure I shows the results of a truly typical CBF measurement at flow rates of 0. 5 ml g-l min-l or less. The equilization of arterial and cerebrovenous 133Xe activities within 15 min and the constancy in A VD02 suggest that accurate values for CBF and CMR02 were obtained. Data for arterial oxygen content (Cao2), A VD02, CBF, and CMROz are given in Table 2 . Since Pa02 values exceeded 100 mm Hg (see Table 1 ), we can conclude from the Cao2 values that the hematocrit was similar in all groups. The CBF and CMR02 values measured in normocapnic animals are typical for barbiturate animals (see Discussion). Hyper capnia induced a 3. 6-fold increase in CBF without causing a significant change in CMR02• Due to this dissociation of CBF and CMR02, A VDOz de creased markedly.
Administration of indomethacin to normocapnic animals reduced CBF by 20%. Since the standard errors were small, this represented a highly signifi cant change (p < 0. 01). As in animals maintained on 70% N20 (Sakabe and Siesjo, 1979; Dahlgren et aI. , 1981) , CMR02 remained unchanged. Although CBF during hypercapnia was only 0. 73 ml g-I min-I; this nevertheless represented an 1. 7-fold increase from control. Thus, although indomethacin reduced ab solute CBF during hypercapnia to one-third of hypercapnic control, the drug did not completely eliminate the CO2 response. Again, CMR02 re mained unchanged.
DISCUSSION
The main results of this study can be summarized as follows. First, in animals maintained on barbitu- 1. Arterial (circles) and cerebrovenous (squares) clearance curves for 1 33 Xe under normocapnia in a low-flow condition induced by barbiturate (phenobarbital, 150 mg kg-1) and indomethacin (10 mg kg-1). Values were as follows: CBF, 0.41 ml g-1 min-1; AVD02, 6.33 /Lmol ml-1 (6.37, 6.16, 6.61, 6.16); and CMR02, 2.53 /Lmol g' min-l. rate anesthesia, indomethacin leads to a reduction in CBF which is so moderate that it could escape detection with any but the most reproducible tech niques. Second, barbiturate anesthesia does not prevent indomethacin from curtailing the circula tory response to induced hypercapnia. Since hyper capnic flow rates in control and indomethacin injected animals differed by a factor of almost 3 (p < 0,001), it remains an unsolved question why the ef fect was not observed by previous workers (Cuy pers et aL, 1978; Wei et aI. , 1980) . Based on the pres ent results, and on previous observations on the effect of indomethacin on pial vessels and isolated middle cerebral artery strips (Vlahov and Betz, 1974; Pickard et aI. , 1976) , it seems justified to con clude that changes in pial artery diameter, or in heat clearance, do not truly reflect alterations in nutri tional blood flow following indomethacin adminis tration. Thus, clear effects of indomethacin on the CO2 responsiveness have been observed in two species by workers who have used quantitative CBF techniques (see introductory remarks). These studies have also revealed that maximal effects are observed with doses as low as 3 mg kg-I, and that the effect is rapid in onset. It should also be re marked that the effect persists for at least 2 -3 h (unpublished observations). It was remarked above that the relative increase in CBF during hypercapnia was not much affected by indomethacin in animals maintained on 70% N20. However, it has been observed before that the CO2 sensitivity, expressed as absolute change in CBF/mm Hg (LlCBFI LlPC02), is reduced in barbitu rate anesthesia and that this reduction bears some relationship to CMR02 (Fujishima et aI. , 1971) . A similar reduction in CO2 sensitivity has been noted in the baboon, in which chloralose anesthesia (as compared to Sernylan anesthesia) reduced both CMR02 and the CO2 responsiveness (Sandor et aL, 1977) . It is clear that the CO2 responsiveness, so calculated, is reduced by indomethacin, although the drug does not decrease CMR02 significantly (Pickard and MacKenzie, 1973; Sakabe and Siesj6, 1979; Dahlgren et aL, 1981) .
The present results, and those previously ob tained in animals under 70% N20, allow a compari son of CO2 responsiveness in N20 and pheno barbital-anesthetized animals, as well as evalua tion of the effects of indomethacin (Fig. 2) . We recog nize the difficulty of calculating LlCBFI LlPC02 values from a curve drawn between only two points. How ever, assuming a roughly linear relationship between P2COz and CBF in the range of 40-80 mm Hg, we calculated approximate indices. As the results show, phenobarbital anesthesia reduced LlCBFILlPC02 to about 40% of the 70% N20 value. Furthermore, in domethacin reduced CO2 responsiveness similarly in N 20-and phenobarbital-anesthetized animals (4to 5-fold).
The present results give information on two further issues, one of which represents an unre solved controversy. The first issue concerns the cerebral metabolic effects of indomethacin. As stated, all studies have shown that indomethacin reduces CBF at constant CMR02. However, in spection of the present data, and those reported by Dahlgren et al. (1981) , shows that in all groups studied (normo-and hypercapnic animals), the mean value for CMR02 was lower in indomethacin treated animals. In order to test the possibility that a true decrease in CMR02 remained undetected due to the small groups studied, we calculated all individ- PCOz ual control and indomethacin CMR02 values as a percentage of the mean and pooled the percentage figures for all four groups (phenobarbital-and N 20anesthetized animals at normal or increased CO2 tensions). A statistical comparison showed that in domethacin causes a reduction in CMR02 by 13% (p < 0.01). The indomethacin-treated animals num bered 29, compared to 27 appropriate controls. The second and controversial issue referred to concerns the effect of hypercapnia on CMROz. As reviewed elsewhere (Siesj6, 1980), various groups have reported decreased, unchanged, or increased CMR02 values in hypercapnia. Our own results, which have demonstrated that hypercapnia of the degree studied presently increases CMR02, have been criticized on grounds that calculations of CMR02 at very high flow rates may be in error (Artru and Michenfelder, 1980) . In order to explore whether pooling of data gives information on this matter, we performed the same statistical maneuver as for the effect of indomethacin on CMR02, using control and indomethacin-treated animals with N20 or phenobarbital anesthesia. The results showed that hypercapnia gives rise to an increase in CMR02 by 12% (p < 0. 05). The hypercapnic groups com prised 31 animals compared to 25 appropriate con trols.
